Downregulation of epidermal growth factor receptor expression contributes to α-TEA's proapoptotic effects in human ovarian cancer cell lines

Journal of Oncology

Volumn , Issue , 2010, Pages

  Kline, Kimberly ^c   Shun, Ming Chieh ^a   Yu, Weiping ^b   Park, Sook Kyung ^b   Sanders, Bob G ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c The University of Texas at Austin   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; ALPHA TOCOPHEROL ETHER LINKED ACETIC ACID ANALOG; ANTINEOPLASTIC AGENT; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; FLICE INHIBITORY PROTEIN; PROTEIN KINASE B; SMALL INTERFERING RNA; SURVIVIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL TYPE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; OVARY CANCER; PROTEIN PHOSPHORYLATION;

EID: 77951668551     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2010/824571     Document Type: Article

References (46)

1. Jemal A., Siegel R., Ward E., Cancer statistics, 2008 CA: A Cancer Journal for Clinicians 2008 58 2 71 96 (Pubitemid 351521864)
2. Parmar M. K., Ledermann J. A., Colombo N., Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial The Lancet 2003 361 9375 2099 2106
3. Eltabbakh G. H., Awtrey C. S., Current treatment for ovarian cancer Expert Opinion on Pharmacotherapy 2001 2 1 109 124
4. Olayioye M. A., Neve R. M., Lane H. A., Hynes N. E., The ErbB signaling network: receptor heterodimerization in development and cancer The EMBO Journal 2000 19 13 3159 3167
5. Yarden Y., Sliwkowski M. X., Untangling the ErbB signalling network Nature Reviews Molecular Cell Biology 2001 2 2 127 137 (Pubitemid 33674041)
6. Alroy I., Yarden Y., The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions FEBS Letters 1997 410 1 83 86 (Pubitemid 27283389)
7. Hynes N. E., Lane H. A., ERBB receptors and cancer: the complexity of targeted inhibitors Nature Reviews Cancer 2005 5 5 341 354
8. Bellacosa A., Kumar C. C., Di Cristofano A., Testa J. R., Activation of AKT kinases in cancer: implications for therapeutic targeting Advances in Cancer Research 2005 94 29 86 (Pubitemid 41202364)
9. Bellacosa A., Testa J. R., Moore R., Larue L., A portrait of AKT kinases: human cancer and animal models depict a family with strong individualities Cancer Biology and Therapy 2004 3 3 268 275 (Pubitemid 41350878)
10. Nicholson K. M., Anderson N. G., The protein kinase B/Akt signalling pathway in human malignancy Cellular Signalling 2002 14 5 381 395
11. Hennessy B. T., Smith D. L., Ram P. T., Lu Y., Mills G. B., Exploiting the PI3K/AKT pathway for cancer drug discovery Nature Reviews Drug Discovery 2005 4 12 988 1004
12. Cheng J. Q., Lindsley C. W., Cheng G. Z., Yang H., Nicosia S. V., The Akt/PKB pathway: molecular target for cancer drug discovery Oncogene 2005 24 50 7482 7492 (Pubitemid 41637988)
13. Carpten J. D., Faber A. L., Horn C., A transforming mutation in the pleckstrin homology domain of AKT1 in cancer Nature 2007 448 7152 439 444 (Pubitemid 47123510)
14. Sethi G., Sung B., Aggarwal B. B., Nuclear factor- B activation: from bench to bedside Experimental Biology and Medicine 2008 233 1 21 31
15. Rasper D. M., Vaillancourt J. P., Hadano S., Cell death attenuation by Usurpin, a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex Cell Death and Differentiation 1998 5 4 271 288 (Pubitemid 28356540)
16. Wrzesien-Kus A., Smolewski P., Sobczak-Pluta A., Wierzbowska A., Robak T., The inhibitor of apoptosis protein family and its antagonists in acute leukemias Apoptosis 2004 9 6 705 715 (Pubitemid 40941199)
17. Deveraux Q. L., Reed J. C., IAP family proteinssuppressors of apoptosis Genes and Development 1999 13 3 239 252
18. Lawson K. A., Anderson K., Menchaca M., Novel vitamin E analogue decreases syngeneic mouse mammary tumor burden and reduces lung metastasis Molecular Cancer Therapeutics 2003 2 437 444
19. Lawson K. A., Anderson K., Snyder R. M., Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis Cancer Chemotherapy and Pharmacology 2004 54 5 421 431 (Pubitemid 39462967)
20. Lawson K. A., Anderson K., Simmons-Menchaca M., Comparison of vitamin E derivatives -TEA and VES in reduction of mouse mammary tumor burden and metastasis Experimental Biology and Medicine 2004 229 9 954 963 (Pubitemid 39539382)
21. Hahn T., Szabo L., Gold M., Ramanathapuram L., Hurley L. H., Akporiaye E. T., Dietary administration of the proapoptotic vitamin E analogue -tocopheryloxyacetic acid inhibits metastatic murine breast cancer Cancer Research 2006 66 19 9374 9378
22. Anderson K., Lawson K. A., Simmons-Menchaca M., Sun L., Sanders B. G., Kline K., -TEA plus cisplatin reduces human cisplatin-resistant ovarian cancer cell tumor burden and metastasis Experimental Biology and Medicine 2004 229 11 1169 1176
23. Zhang S., Lawson K. A., Simmons-Menchaca M., Sun L., Sanders B. G., Kline K., Vitamin E analog -TEA and celecoxib alone and together reduce human MDA-MB-435-FL-GFP breast cancer burden and metastasis in nude mice Breast Cancer Research and Treatment 2004 87 2 111 121
24. Jia L., Yu W., Wang P., Sanders B. G., Kline K., In vivo and in vitro studies of anticancer actions of -TEA for human prostate cancer cells Prostate 2008 68 8 849 860 (Pubitemid 351845216)
25. Shun M.-C., Yu W., Gapor A., Pro-apoptotic mechanisms of action of a novel vitamin E analog ( -TEA) and a naturally occurring form of vitamin E ( -tocotrienol) in MDA-MB-435 human breast cancer cells Nutrition and Cancer 2004 48 1 95 105 (Pubitemid 38823551)
26. Anderson K., Simmons-Menchaca M., Lawson K. A., Atkinson J., Sanders B. G., Kline K., Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E succinate and vitamin E analogue, -TEA Cancer Research 2004 64 12 4263 4269 (Pubitemid 38802432)
27. Yu W., Shun M.-C., Anderson K., Chen H., Sanders B. G., Kline K., -TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells Apoptosis 2006 11 10 1813 1823
28. Vlahos C. J., Matter W. F., Hui K. Y., Brown R. F., A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)- 8-phenyl-4H-1-benzopyran-4- one (LY294002) Journal of Biological Chemistry 1994 269 7 5241 5248
29. Okada T., Sakuma L., Fukui Y., Hazeki O., Ui M., Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase Journal of Biological Chemistry 1994 269 5 3563 3567
30. Niedbala M., Alsbeih G., Ng C. E., Raaphorst G. P., Equivalence of pulsed-dose-rate to low-dose-rate irradiation in tumor and normal cell lines Radiation Research 2001 155 2 297 303 (Pubitemid 32125980)
31. Behrens B. C., Hamilton T. C., Masuda H., Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues Cancer Research 1987 47 2 414 418
32. Yu W., Heim K., Qian M., Simmons-Menchaca M., Sanders B. G., Kline K., Evidence for role of transforming growth factor- in RRR- -tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells Nutrition and Cancer 1997 27 3 267 278
33. Yu W., Israel K., Liao Q. Y., Aldaz C. M., Sanders B. G., Kline K., Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis Cancer Research 1999 59 4 953 961
34. Sithanandam G., Fornwald L. W., Fields J., Anderson L. M., Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549 Oncogene 2005 24 11 1847 1859
35. Yuan Z.-Q., Feldman R. I., Sussman G. E., Coppola D., Nicosia S. V., Cheng J. Q., AKT2 inhibition of cisplatin-induced JNK/p38 and bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance Journal of Biological Chemistry 2003 278 26 23432 23440
36. Jiang K., Coppola D., Crespo N. C., The phosphoinositide 3-OH kinase/AKT2 pathway as a critical target for farnesyltransferase inhibitor-induced apoptosis Molecular and Cellular Biology 2000 20 1 139 148
37. Dan H. C., Jiang K., Coppola D., Phosphatidylinositol-3-OH kinase/AKT and survivin pathways as critical targets for geranylgeranyltransferase I inhibitor-induced apoptosis Oncogene 2004 23 3 706 715
38. Naito M., Katayama R., Ishioka T., Cellular FLIP inhibits -catenin ubiquitylation and enhances Wnt signaling Molecular and Cellular Biology 2004 24 19 8418 8427
39. Li X., Lu Y., Liang K., Liu B., Fan Z., Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells Breast Cancer Research 2005 7 5 R589 R597
40. Yuste L., Montero J. C., Esparis-Ogando A., Pandiella A., Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin Cancer Research 2005 65 15 6801 6810
41. del Peso L., Gonzalez-Garcia M., Page C., Herrera R., Nunez G., Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt Science 1997 278 5338 687 689
42. Shanker M., Gopalan B., Patel S., Bocangel D., Chada S., Ramesh R., Vitamin E succinate in combination with mda-7 results in enhanced human ovarian tumor cell killing through modulation of extrinsic and intrinsic apoptotic pathways Cancer Letters 2007 254 2 217 226
43. Zhang H., Berezov A., Wang Q., ErbB receptors: from oncogenes to targeted cancer therapies Journal of Clinical Investigation 2007 117 8 2051 2058
44. Delord J. P., Allal C., Canal M., Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma Annals of Oncology 2005 16 12 1889 1897
45. Chaudhuri D., Orsulic S., Ashok B. T., Antiproliferative activity of sulforaphane in Akt-overexpressing ovarian cancer cells Molecular Cancer Therapeutics 2007 6 1 334 345
46. Petronelli A., Saulle E., Pasquini L., High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide Cancer Letters 2009 282 2 214 228